Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-70 of 139 for Epilepsy

Edit search filters
  1. Study of the Incidence of Electrographic Status Epilepticus and Seizures of PICU Patients at National Children’s Hospital in Hanoi, Vietnam.

    Rochester, MN

  2. Network Neuro-modulation for Mesial Temporal Lobe Epilepsy

    Rochester, MN

  3. Study Of NRTX-1001 Neural Cell Therapy In Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

    Scottsdale/Phoenix, AZ

  4. A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke

    Rochester, MN

  5. Efficacy And Safety Of GWP42003-P Oral Solution In Children With Epilepsy With Myoclonic-atonic Seizures

    Rochester, MN

  6. 7T MR Imaging in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)

    Scottsdale/Phoenix, AZ

  7. Study Evaluating The Safety And Efficacy Of Rap-219 In Adult Participants With Refractory Focal Epilepsy

    Rochester, MN

  8. Adjunctive Ganaxolone (GNX) Treatment In Children And Adults With Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC)

    Rochester, MN

  9. Inpatient, Dose-Ranging Study Of Staccato Alprazolam In Epilepsy With Predictable Seizure Pattern

    Jacksonville, FL

  10. Phase 2 Efficacy, Safety, And Tolerability Study Of Natalizumab In Focal Epilepsy

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer